Back to Search
Start Over
Early Kinetics of the HLA Class I-Associated Peptidome of MVA.HIVconsv-Infected Cells.
- Source :
-
Journal of virology [J Virol] 2015 Jun; Vol. 89 (11), pp. 5760-71. Date of Electronic Publication: 2015 Mar 25. - Publication Year :
- 2015
-
Abstract
- Unlabelled: Cytotoxic T cells substantially contribute to the control of intracellular pathogens such as human immunodeficiency virus type 1 (HIV-1). Here, we evaluated the immunopeptidome of Jurkat cells infected with the vaccine candidate MVA.HIVconsv, which delivers HIV-1 conserved antigenic regions by using modified vaccinia virus Ankara (MVA). We employed liquid chromatography-tandem mass spectrometry (LC-MS/MS) to identify 6,358 unique peptides associated with the class I human leukocyte antigen (HLA), of which 98 peptides were derived from the MVA vector and 7 were derived from the HIVconsv immunogen. Human vaccine recipients responded to the peptide sequences identified by LC-MS/MS. Peptides derived from the conserved HIV-1 regions were readily detected as early as 1.5 h after MVA.HIVconsv infection. Four of the seven conserved peptides were monitored between 0 and 3.5 h of infection by using quantitative mass spectrometry (Q-MS), and their abundance in HLA class I associations reflected levels of the whole HIVconsv protein in the cell. While immunopeptides delivered by the incoming MVA vector proteins could be detected, all early HIVconsv-derived immunopeptides were likely synthesized de novo. MVA.HIVconsv infection generally altered the composition of HLA class I-associated human (self) peptides, but these changes corresponded only partially to changes in the whole cell host protein abundance.<br />Importance: The vast changes in cellular antigen presentation after infection of cells with a vectored vaccine, as shown here for MVA.HIVconsv, highlight the complexity of factors that need to be considered for efficient antigen delivery and presentation. Identification and quantitation of HLA class I-associated peptides by Q-MS will not only find broad application in T-cell epitope discovery but also inform vaccine design and allow evaluation of efficient epitope presentation using different delivery strategies.<br /> (Copyright © 2015, Ternette et al.)
- Subjects :
- Chromatography, Liquid
Genetic Vectors
Humans
Jurkat Cells
T-Lymphocytes, Cytotoxic immunology
Tandem Mass Spectrometry
Time Factors
Vaccines, Synthetic immunology
Vaccinia virus genetics
Vaccinia virus immunology
AIDS Vaccines immunology
Antigens, Viral analysis
HIV-1 immunology
Histocompatibility Antigens Class I metabolism
Peptides analysis
T-Lymphocytes, Cytotoxic chemistry
Subjects
Details
- Language :
- English
- ISSN :
- 1098-5514
- Volume :
- 89
- Issue :
- 11
- Database :
- MEDLINE
- Journal :
- Journal of virology
- Publication Type :
- Academic Journal
- Accession number :
- 25810538
- Full Text :
- https://doi.org/10.1128/JVI.03627-14